Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More Food Industry News Shoreline Equity Partners joins forces with Prime Meats to amplify market presence In a significant move within the food distribution sector, Shoreline Equity Partners, LLC, known for its strategic investments… byPallavi MadhirajuApril 28, 2024